OPRX
What one share of OptimizeRx holds
Services – Business Services, NEC
OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care.
OptimizeRx’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $5.15 |
|---|---|
| Profit | $0.24 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.96 |
| Cash and investments | $1.28 |
| Debt | $1.01 |
| Book value | $6.96 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $0.35 | −$0.08 | $0.00 | −$0.11 | — | $0.30 |
| 2013 | $0.66 | −$0.06 | $0.00 | $0.16 | — | $0.34 |
| 2014 | $0.81 | −$0.12 | $0.00 | −$0.01 | — | $0.60 |
| 2015 | $0.88 | −$0.07 | $0.00 | $0.06 | — | $0.92 |
| 2016 | $0.78 | −$0.16 | $0.02 | −$0.07 | — | $0.79 |
| 2017 | $1.24 | −$0.21 | $0.00 | −$0.15 | — | $0.64 |
| 2018 | $1.79 | $0.02 | $0.00 | $0.06 | — | $1.53 |
| 2019 | $1.84 | −$0.23 | $0.01 | −$0.13 | — | $3.07 |
| 2020 | $2.92 | −$0.15 | $0.00 | −$0.43 | — | $3.28 |
| 2021 | $3.46 | $0.02 | $0.01 | $0.04 | — | $7.36 |
| 2022 | $3.51 | −$0.64 | $0.00 | $0.59 | — | $6.90 |
| 2023 | $4.18 | −$1.03 | $0.01 | −$0.43 | — | $6.97 |
| 2024 | $5.04 | −$1.10 | $0.01 | $0.26 | — | $6.34 |
| 2025 | $5.76 | $0.27 | $0.00 | $0.98 | — | $6.84 |